The United States represents a dominant force in the global Biologic Imaging Reagents Market, supported by advanced healthcare infrastructure, strong research capabilities, and high adoption of diagnostic imaging technologies for diseases such as Cancer and Cardiovascular Diseases. The country plays a central role in driving innovation, demand, and commercialization of biologic imaging...